Estimated financial data (e) (USD)
Net income 2021
Net Debt 2021
P/E ratio 2021
Net income 2022
Net Debt 2022
P/E ratio 2022
Capi. / Sales 2021
Capi. / Sales 2022
Nbr of Employees
Oncotelic Therapeutics, Inc., formerly Mateon Therapeutics, Inc., is an immuno-oncology company. The Company is engaged in development of ribonucleic acid (RNA) therapeutics as well as small molecule drugs against cancer and infectious diseases. The CompanyÔÇÖs pipeline includes ArtiVeda/ArtiShield, OT-101, CA4P and Oxi4503. The ArtiVeda/ArtiShield is a derivative from the plant Artemisia. Its immuno-oncology drug...
Ratings of Mateon Therapeutics, Inc.
All news about MATEON THERAPEUTICS, INC.
07/20 Oncotelic Therapeutics, Inc. Announces Board Changes
07/20 ONCOTELIC THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8..
07/02 ONCOTELIC THERAPEUTICS : Entry into Securities Purchase Agreement and Issuance o..
07/02 ONCOTELIC THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unreg..
07/02 Oncotelic Therapeutics, Inc. Announces Executive Changes
06/15 ONCOTELIC THERAPEUTICS : CLOSES COVID-19 CLINICAL TRIAL EARLY (Form 8-K)
06/15 ONCOTELIC THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (..
06/15 ONCOTELIC THERAPEUTICS : Closes covid-19 clinical trial early.
06/15 Oncotelic Therapeutics, Inc. Closes Covid-19 Clinical Trial Early
05/25 Oncotelic Therapeutics, Inc. announced that it has received $0.20375 million ..
05/07 ONCOTELIC THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unreg..
04/21 ONCOTELIC THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (..
04/21 ONCOTELIC THERAPEUTICS : Announces positive top line data for arti-19 clinical t..
04/19 Oncotelic therapeutics, inc. announced synergy between ot-101 and il-2 (prole..
04/15 ONCOTELIC THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
News in other languages on MATEON THERAPEUTICS, INC.
- No features available -
Chart MATEON THERAPEUTICS, INC.
Number of Analysts
Last Close Price
Average target price
Spread / Average Target